Test Price
2,800 AED✅ Home Collection Available
PRPH2 Gene Sequencing (Fundus Albipunctatus) Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing.
Premium Logistics: Hospital-Grade Home Collection via ISO Certified Cold-Chain and VIP Mobile Phlebotomy (8 AM – 11 PM daily).
Clinical Guidance: Telephonic Post-Test Result Interpretation by a DHA-Licensed Consultant Medical Geneticist.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The PRPH2 Gene NGS Test screens the entire coding region of the PRPH2 gene for pathogenic variants linked to fundus albipunctatus, a slowly progressive inherited retinal dystrophy. Early molecular confirmation enables precise ophthalmologic monitoring and family planning.
Our NGS Test vs. Traditional Sanger Sequencing
| Feature | Our NGS Test | Sanger Sequencing |
|---|---|---|
| Gene Coverage | Full PRPH2 gene (exons, splice sites, deep intronic regions) | Selected exons only |
| Analytical Sensitivity | 99.9% (ultra-deep 100x coverage) | ~95% |
| Turnaround Time | 21 – 28 Days | 35 – 49 Days |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403: "Fundus albipunctatus often mimics other retinal conditions; this NGS panel gives families a definitive molecular answer, enabling personalised follow-up. Please remember that a genetic result is a piece of your clinical puzzle — it must always be interpreted alongside a comprehensive eye exam and genetic counselling."
Advisory: Medication & Clinical Precautions
Do not discontinue any prescribed medication, eye drops, or therapy regimen without consulting your ophthalmologist. This genetic test is designed for hereditary confirmation and does not replace urgent ophthalmic evaluation or emergency care. Retain your current treatment plan until directed otherwise by your specialist.
Safety Exclusion Criteria & Emergency Red Flags
- Exclusion: Allogeneic bone marrow transplant within 6 months (donor DNA may confound results). Inform the laboratory prior to sample submission.
- Emergency Red Flag – Seek immediate ophthalmic care: Sudden vision loss, acute eye pain, or new onset of floaters or flashes.
- This genetic test is not intended for acute diagnosis; it confirms a chronic hereditary condition.
Patient FAQ & Clinical Guidance
1. What is the PRPH2 gene test for fundus albipunctatus?
This test analyses the PRPH2 gene for pathogenic variants causing fundus albipunctatus, a hereditary retinal dystrophy affecting night and peripheral vision. The NGS method reads the entire gene sequence, providing high diagnostic accuracy. Confirmatory testing guides ophthalmologic surveillance and family risk assessment.
2. Why is genetic counselling mandatory before this test?
A pre-test genetic counselling session draws a pedigree, explains inheritance patterns, and ensures you are psychologically prepared for possible outcomes. It is a DHA-mandated step that protects your autonomy and allows for informed consent before any DNA sample is processed.
3. How is the sample collected and when will I receive the result?
A simple blood draw, one drop on an FTA card, or extracted DNA is collected; turnaround is 21 – 28 days from laboratory receipt. You may book a VIP home phlebotomy (8 AM – 11 PM) via WhatsApp +971 54 548 8731. All samples travel under ISO-certified cold-chain protocols.
4. What does a positive result mean for my family?
A pathogenic variant in PRPH2 confirms a diagnosis of fundus albipunctatus and implies a 50% risk of transmission to offspring in an autosomal dominant pattern. Cascade screening for at-risk relatives is strongly recommended. A negative result does not entirely rule out other genetic causes of retinal dystrophy.
UAE Regulatory & Data Privacy Adherence
All genetic data processing is conducted in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical testing safety and patient consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. DNA Labs UAE is an ISO 9001:2015 Certified facility (INT/EGQ/2509DA/3139). DHA Facility License: 1143.
Clinical & Logistical Metadata
| Test Name | PRPH2 Gene Sequencing (Fundus Albipunctatus) – NGS |
| Price (AED) | 2,800 AED |
| Turnaround Time | 21 – 28 Days |
| Sample Type / Matrix | Peripheral Whole Blood, FTA Card Spot, or Extracted DNA |
| Methodology Used | Next-Generation Sequencing (NGS) – Full Gene Coverage with 100x Ultra-Deep Coverage |
| ICD-10-CM Code | H35.52 |
| LOINC Code | 52084-6 |
| DHA Facility License & Address | License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians